Short-course antibiotic treatment of 4782 culture-proven cases of group A streptococcal tonsillopharyngitis and incidence of poststreptococcal sequelae

被引:41
作者
Adam, D
Scholz, H
Helmerking, M
机构
[1] Univ Munich, Dr Von Haunerschen Kinderspital, Dept Antimicrobial Therapy, D-80337 Munich, Germany
[2] Algora Clin Res Inst, Munich, Germany
[3] Municipal Hosp Buch, Inst Infect Dis Microbiol & Hygien, Berlin, Germany
基金
英国惠康基金;
关键词
D O I
10.1086/315709
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A large-scale study with a 1-year follow-up was performed to compare 10 days of penicillin V with a short-course treatment (5 days) of other oral antibiotics in the treatment of group A beta-hemolytic streptococcus (GABHS) tonsillopharyngitis, to evaluate the efficacy and the incidence of poststreptococcal sequelae. The clinical response rates after completion of therapy were 94.5% in the 5-day group and 93.4% in the penicillin group (P < .001, equivalence test). The GABHS eradication rates were 83.3% in the 5-day group and 84.4% in the penicillin group (P = .022, equivalence test). Poststreptococcal sequelae were rare (5 patients) and did not occur in the context of this study. The efficacy of 5-day antibiotic regimens was equivalent to 10 days of penicillin V, but resolution of clinical symptoms was faster in the 5-day group (P < .001, Fisher's exact test). Recurrent tonsillopharyngitis occurs more frequently after treatment with penicillin (P = .03, Fisher's exact test).
引用
收藏
页码:509 / 516
页数:8
相关论文
共 30 条
  • [1] Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group a streptococcal tonsillopharyngitis in children
    Adam, D
    Scholz, H
    Aspe, C
    Berzel, HG
    Bulle, D
    Fritz, HP
    Grosse, V
    Hartmann, W
    Heil, RP
    Hirschbrunn, P
    HubschmannMehl, U
    Just, J
    Kielhorn, A
    Knauer, B
    Maurer, L
    Muller, K
    Niehaus, G
    Onken, D
    Raff, W
    Reineke, J
    SchulzeBuxloh, A
    Schumann, D
    Steiner, M
    Szdzuy, C
    vanStiphout, P
    Weh, M
    Winter, H
    Wolff, P
    Zinke, M
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (09) : 712 - 717
  • [2] ADAM D, 1998, 38 INT C ANT AG CHEM, P575
  • [3] COMPARATIVE EFFICACY AND SAFETY OF 4-DAY CEFUROXIME AXETIL AND 10-DAY PENICILLIN TREATMENT OF GROUP-A BETA-HEMOLYTIC STREPTOCOCCAL PHARYNGITIS IN CHILDREN
    AUJARD, Y
    BOUCOT, I
    BRAHIMI, N
    CHICHE, D
    BINGEN, E
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (04) : 295 - 300
  • [4] Diagnosis and management of group A streptococcal pharyngitis: A practice guideline
    Bisno, AL
    Gerber, MA
    Gwaltney, JM
    Kaplan, EL
    Schwartz, RH
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) : 574 - 583
  • [5] GROUP-A STREPTOCOCCAL INFECTIONS - THE CHANGING SCENE
    BISNO, AL
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 1995, 8 (02) : 117 - 122
  • [6] BROOK I, 1984, REV INFECT DIS, V6, P601
  • [7] QUANTITATIVE MEASUREMENT OF BETA-LACTAMASE IN TONSILS OF CHILDREN WITH RECURRENT TONSILLITIS
    BROOK, I
    YOCUM, P
    [J]. ACTA OTO-LARYNGOLOGICA, 1984, 98 (5-6) : 556 - 559
  • [8] Epidemiology and prevention of group A streptococcal infections: Acute respiratory tract infections, skin infections, and their sequelae at the close of the twentieth century
    Carapetis, JR
    Currie, BJ
    Kaplan, EL
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 28 (02) : 205 - 210
  • [9] INTERRELATIONSHIP BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS IN DETERMINING DOSAGE REGIMENS FOR BROAD-SPECTRUM CEPHALOSPORINS
    CRAIG, WA
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 22 (1-2) : 89 - 96
  • [10] DAJANI A, 1995, PEDIATRICS, V96, P758